1)Howard RS, Lee AJ: Encephalitis lethargica. A report of four recent cases. Brain 110: 19-33, 1987
2)杤久保早苗, 渡邉多佳子, 本間真理, 山本悌司: 嗜眠性脳炎と思われる6例の経験. 神経内科55: 66-70, 2001
3)Vitaliani R, Mason W, Ances B, Zwerdling T, Dalmau J, et al: Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58: 594-604, 2005
4)Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, et al: Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61: 25-36, 2007
5)Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, et al: Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12: 157-165, 2013
6)Titulaer MJ, Dalmau J: Seizures as first symptoms of anti-NMDA receptor encephalitis are more common in men. Neurology 82: 550-551, 2014
7)Prüss H, Dalmau J, Harms L, Höltje M, Ahnert-Hilger G, et al: Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 75: 1735-1739, 2010
8)Wada-Isoe K, Kusumi M, Kai T, Awaki E, Shimoda M, et al: Epidemiological study of acute encephalitis in Tottori Prefecture, Japan. Eur J Neurol 15: 1075-1079, 2008
9)Singh TD, Fugate JE, Rabinstein AA: The spectrum of acute encephalitis: causes, management, and predictors. Neurology 84: 359-366, 2015
10)Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, et al: Cognition and immunity; antibody impairs memory. Immunity 21: 179-188, 2004
receptor autoantibodies in autoimmune encephalitis. J Neurosci 34: 8151-8163, 2014
12)Lee CH, Lin JJ, Lin KJ, Chang BL, Hsieh HY, et al: Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma. J Neurol Sci 341: 36-40, 2014
13)Sacks O: Awakenings. Harper Perennial, London, 1973, pp319-321
14)Schmitt SH, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, et al: Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79: 1094-1100, 2012
15)Waterman K, Wada JA: Frontal lobe epilepsy. Gram L, Dam M (eds): Comprehensive Epidemiology. Raven Press, New York, 1991, pp205-208
16)高橋幸利: 厚生労働科学研究費補助金障害者対策総合研究事業 急性脳炎・脳症のグルタミン酸受容体自己免疫病態の解明・早期診断・治療法確立に関する臨床研究 平成20年度〜22年度 総合研究報告書. pp165-175
17)Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, et al: Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70: 504-511, 2008
18)Iizuka T, Yoshii S, Kan S, Hamada J, Dalmau J, et al: Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 257: 1686-1691, 2010
19)高橋幸利, 保立麻美子, 植田佑樹, 山口解冬, 那須裕郷: グルタミン酸受容体自己抗体. Brain Nerve 65: 345-353, 2013
20)Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R: Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10: 63-74, 2011
21)Martinez-Fernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, et al: Analysis of complement and plasma cells in the brains of patients with anti-NMDAR encephalitis. Neurology 77: 589-593, 2011
22)Wechsler IS: Clinical Neurology with an Introduction to the History of Neurology. WB Saunders, Philadelphia 1963, pp393-398
23)高橋幸利: 厚生労働科学研究費補助金障害者対策総合研究事業 急性脳炎・脳症のグルタミン酸受容体自己免疫病態の解明・早期診断・治療法確立に関する臨床研究 平成20年度〜22年度 総合研究報告書. pp185-198
24)髙橋幸利, 森 達夫, 大星大観, 束本和紀, 渡辺陽和: 神経疾患と抗NMDA型グルタミン酸受容体抗体. 日児誌118: 1695-1707, 2014